Meier-Gorlin syndrome: genes and variants
Explore variant evidence for Meier-Gorlin syndrome across 2 analyzed proteins (ORC1, MCM5). Linked ClinVar records include 7 pathogenic or likely pathogenic variants, 27 variants of uncertain significance and 6 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Meier-Gorlin syndrome
ORC1: Origin recognition complex subunit 1
It helps mark replication origins and assemble the prereplication complex needed to license DNA replication once per cell cycle. Biallelic pathogenic variants cause Meier-Gorlin syndrome, characterized by severe growth restriction, microtia, and absent or small patellae.
6 ClinVar pathogenic / likely pathogenic and 31 uncertain variants in ORC1 have source records linked to Meier-Gorlin syndrome. Association strength is not clinical gene validity.
MCM5: DNA replication licensing factor MCM5
It functions within the MCM2-7 helicase complex required for origin licensing and DNA unwinding during replication. Because its expression tracks proliferative activity, altered abundance is frequently observed in cancers and is used as a proliferation-related biomarker.
1 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in MCM5 have source records linked to Meier-Gorlin syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MCM3.
Where Meier-Gorlin syndrome variants cluster
- ORC1 BAH (positions 45–171): 4 of 6 ClinVar pathogenic / likely pathogenic variants, 4.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Meier-Gorlin syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ORC1 R105W | 105 | BAH | Pathogenic / likely pathogenic (★★) |
| ORC1 R105Q | 105 | BAH | Pathogenic / likely pathogenic (★★) |
| ORC1 L622P | 622 | Necessary and sufficient for ORC complex assembl | Pathogenic / likely pathogenic (★) |
| ORC1 E73K | 73 | BAH | Pathogenic / likely pathogenic (★) |
| MCM5 T466I | 466 | MCM C-terminal AAA(+) ATPase | Pathogenic / likely pathogenic |
| ORC1 S828F | 828 | Necessary and sufficient for ORC complex assembl | Pathogenic / likely pathogenic |
| ORC1 E127G | 127 | BAH | Pathogenic / likely pathogenic |
Diseases related to Meier-Gorlin syndrome
- Fetal anomalies with a likely genetic cause, also linked to ORC1
Frequently asked questions
Which genes have records linked to Meier-Gorlin syndrome?
This view contains 2 analyzed proteins: ORC1, MCM5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 7 pathogenic or likely pathogenic variants, 27 variants of uncertain significance and 6 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 59 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center